Profile data is unavailable for this security.
About the company
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
- Revenue in USD (TTM)7.00k
- Net income in USD-19.13m
- Incorporated2005
- Employees1.00
- LocationAlaunos Therapeutics Inc2617 Bissonnet St, Suite 225HOUSTON 77005United StatesUSA
- Phone+1 (617) 259-1970
- Fax+1 (617) 241-2855
- Websitehttps://alaunos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | 0.00 | -14.17m | 3.01m | 9.00 | -- | 0.2465 | -- | -- | -20.07 | -20.07 | 0.00 | 10.30 | 0.00 | -- | -- | 0.00 | -90.97 | -132.36 | -109.07 | -165.45 | -- | -- | -- | -27,892.32 | -- | -972.73 | 0.0339 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
| Revelation Biosciences Inc | 0.00 | -15.90m | 3.08m | 9.00 | -- | 1.18 | -- | -- | -29.75 | -29.75 | 0.00 | 0.6939 | 0.00 | -- | -- | 0.00 | -112.35 | -- | -253.32 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 98.89 | -- | -- | -- |
| Aditxt Inc | 329.75k | -43.31m | 3.12m | 47.00 | -- | 0.0027 | -- | 9.47 | -3,088.09 | -3,088.09 | 12.12 | 131.74 | 0.0185 | 0.6082 | 0.8393 | 7,015.96 | -242.33 | -192.78 | -1,548.63 | -321.59 | -46.09 | -- | -13,105.77 | -7,208.65 | 0.0458 | -3.53 | 0.5084 | -- | -30.90 | -- | -18.11 | -- | -- | -- |
| Avenue Therapeutics Inc | 0.00 | -5.87m | 3.13m | 3.00 | -- | 0.5469 | -- | -- | -3.02 | -3.02 | 0.00 | 4.00 | 0.00 | -- | -- | 0.00 | -177.94 | -186.91 | -- | -287.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -192.15 | -- | -- | -- |
| InMed Pharmaceuticals Inc | 4.60m | -7.68m | 3.15m | 13.00 | -- | 0.2285 | -- | 0.6851 | -1.33 | -1.33 | 0.6027 | 1.03 | 0.3546 | 2.44 | 14.99 | -- | -59.20 | -92.09 | -69.92 | -113.17 | 23.94 | -- | -166.94 | -543.29 | 3.78 | -- | 0.00 | -- | 11.18 | -- | 3.42 | -- | -19.10 | -- |
| Alaunos Therapeutics Inc | 7.00k | -19.13m | 3.18m | 1.00 | -- | 0.8428 | -- | 454.00 | -11.95 | -11.95 | 0.0044 | 2.36 | 0.0004 | -- | 1.75 | 7,000.00 | -117.34 | -74.83 | -143.58 | -89.57 | -- | -- | -273,271.40 | -10,508.06 | -- | -- | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| Petros Pharmaceuticals Inc | 4.12m | -20.64m | 3.18m | 21.00 | -- | 0.3664 | -- | 0.7724 | -6.54 | -6.54 | 1.00 | 0.988 | 0.1529 | 0.6795 | 1.89 | 196,223.30 | -26.18 | -32.43 | -39.25 | -68.05 | 70.21 | 62.04 | -171.23 | -201.70 | 1.26 | -- | 0.4539 | -- | -2.83 | -16.15 | 31.06 | -- | -- | -- |
| Entero Therapeutics Inc | 0.00 | -9.69m | 3.27m | 15.00 | -- | 0.2219 | -- | -- | -15.29 | -15.87 | 0.00 | 24.07 | 0.00 | -- | -- | 0.00 | -20.88 | -295.92 | -26.29 | -1,599.51 | -- | -- | -- | -- | -- | -2,709.72 | 0.0025 | -- | -- | -- | -7.55 | -- | -- | -- |
| Talis Biomedical Corp | 408.00k | -51.03m | 3.30m | 99.00 | -- | 0.0678 | -- | 8.08 | -28.02 | -28.02 | 0.224 | 26.69 | 0.0042 | -- | 1.53 | 4,121.21 | -52.13 | -68.18 | -57.23 | -74.22 | 95.10 | -- | -12,506.37 | -1,615.96 | -- | -- | 0.00 | -- | -55.65 | -2.24 | 45.13 | -- | -1.83 | -- |
| Bio Path Holdings Inc | 0.00 | -11.60m | 3.32m | 10.00 | -- | 1.58 | -- | -- | -17.91 | -17.91 | 0.00 | 0.5655 | 0.00 | -- | -- | 0.00 | -199.23 | -70.80 | -321.87 | -76.87 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -15.94 | -- | -- | -- |
| ProtoKinetix, Inc. | 0.00 | -369.97k | 3.38m | 0.00 | -- | 8.33 | -- | -- | -0.0011 | -0.0011 | 0.00 | 0.0012 | 0.00 | -- | -- | -- | -78.67 | -696.88 | -85.20 | -785.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 78.22 | -- | 10.78 | -- |
Data as of Nov 08 2024. Currency figures normalised to Alaunos Therapeutics Inc's reporting currency: US Dollar USD
13.75%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MSD Partners LPas of 30 Jun 2024 | 101.01k | 6.31% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 62.41k | 3.90% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 22.24k | 1.39% |
| Geode Capital Management LLCas of 30 Jun 2024 | 16.36k | 1.02% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 5.02k | 0.31% |
| UBS Securities LLCas of 30 Jun 2024 | 4.47k | 0.28% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2024 | 2.90k | 0.18% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 2.42k | 0.15% |
| Citadel Securities LLCas of 30 Jun 2024 | 1.69k | 0.11% |
| Allred Capital Management LLCas of 30 Jun 2024 | 1.69k | 0.11% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
